FTC action on PBMs could be just what the doctor ordered to improve patient outcomes
A primer on prescription drug prices, pharmacy benefit managers, government action, and why physicians need to be heard. Medical...
FTC action on PBMs could be just what the doctor ordered to improve patient outcomes
Drug Pricing Oversight to Get Prime Focus Under New Congress
Will your insurance company cover the copay for a costly drug?
Lawsuit filed against national insulin manufacturers by Kansas Attorney General
The next drug pricing battle: PBMs
Inequity in Pharmacy Benefit Managers’ Drug Pricing Practices in Oregon Raises Serious Questions
AARP: An Organization that Stands with PBM Kickbacks and Hidden Prices
Consumers Overpay for Generic Alternatives, Study Results Show
In Memoriam: Morris Gortler
CVC to CMS: Ongoing Cuts Undermine Healthcare Access and Quality Care
Replacing White Bagging Mandates With Market Competition Will Improve Patient Outcome
Four in 10 Americans Cut Spending to Cover Healthcare Costs
Cut the Red Tape Preventing Medication Access
Local Opinion: FTC is right to investigate pharmacy benefit managers
These 'Rebates' Don't Result in Savings
Hospitals and for-profit PBMs are diverting billions in 340B savings from patients in need
Consumer Alert: Paying too much for prescription drugs? A middleman may be to blame
Pharmacy Benefit Mafia: The Secret Health Care Monopolies Jacking Up Drug Prices Abusing Patients
Guest Column: PBMs are hurting Texans with disabilities
AG Balderas Announces $13.7 Million Settlement With Centene Corporation Over PBM Investigation